United Therapeutics CEO Martine Rothblatt disposes of common shares worth $4.64 million
UTHR•Trust transaction in United Therapeutics common stock
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported a trust transaction in common stock on Sept. 4, 2026.
- Trust acquired 9,500 shares at USD 117.76 via option exercise.
- Trust sold 9,500 shares at weighted-average prices from USD 485.85 to USD 491.69.
- Trust holdings ended at 324,443 shares.
